Squarepoint’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.4M Sell
188,292
-158,429
-46% -$4.4M 0.01% 1546
2026
Q1
$6.48M Buy
+346,721
New +$6.62M 0.01% 1320
2025
Q1
Sell
-117,074
Closed -$2.84M 5376
2024
Q4
$2.84M Buy
117,074
+52,488
+81% +$1.5M ﹤0.01% 2101
2024
Q3
$2.4M Buy
64,586
+1,814
+3% +$67.7K ﹤0.01% 1942
2024
Q2
$2.99M Buy
62,772
+32,602
+108% +$1.43M ﹤0.01% 1754
2024
Q1
$1.15M Sell
30,170
-1,092
-3% -$35.5K ﹤0.01% 2490
2023
Q4
$976K Sell
31,262
-15,816
-34% -$568K ﹤0.01% 2541
2023
Q3
$1.89M Buy
47,078
+31,165
+196% +$1.46M ﹤0.01% 1863
2023
Q2
$837K Buy
+15,913
New +$969K ﹤0.01% 2290
2023
Q1
Sell
-122,691
Closed -$5.96M 3785
2022
Q4
$5.96M Buy
122,691
+107,972
+734% +$6.77M 0.02% 755
2022
Q3
$1.04M Buy
14,719
+10,130
+221% +$867K 0.01% 1747
2022
Q2
$325K Buy
+4,589
New +$296K ﹤0.01% 2256
2021
Q3
Sell
-7,813
Closed -$1.19M 3404
2021
Q2
$1.19M Buy
+7,813
New +$1.03M ﹤0.01% 1515
2020
Q1
Sell
-41,841
Closed -$1.47M 2476
2019
Q4
$1.47M Sell
41,841
-25,596
-38% -$845K 0.01% 1084
2019
Q3
$1.74M Sell
67,437
-35,475
-34% -$1.08M 0.02% 916
2019
Q2
$3.02M Buy
102,912
+24,751
+32% +$714K 0.03% 625
2019
Q1
$2.67M Buy
78,161
+43,703
+127% +$1.55M 0.03% 657
2018
Q4
$1.1M Buy
34,458
+7,458
+28% +$291K 0.01% 886
2018
Q3
$1.3M Sell
27,000
-13,700
-34% -$561K 0.02% 877
2018
Q2
$1.26M Buy
+40,700
New +$952K 0.02% 807
2018
Q1
Sell
-16,695
Closed -$259K 2119
2017
Q4
$259K Buy
+16,695
New +$248K ﹤0.01% 1623

Other funds holding STAA

Squarepoint's STAA Position: Q2 2026 in Review

Squarepoint reduced its STAAR Surgical (STAA) stake by 46% in Q2 2026, selling an estimated $4.4M and leaving 188,292 shares worth $5.4M. The position accounts for 0.01% of the portfolio, ranked #1546.

Squarepoint first reported a position in STAA in Q4 2017 and has held it in 21 quarters since. The position peaked at $6.48M in Q1 2026. 200 funds tracked by Wall St. Rank hold STAA as of Q2 2026.

  • Squarepoint held 188,292 shares of STAAR Surgical worth $5.4M as of Q2 2026.
  • Squarepoint sold 158,429 STAAR Surgical shares in Q2 2026, an estimated $4.4M.
  • STAAR Surgical made up 0.01% of Squarepoint's portfolio in Q2 2026, its #1546 holding.
  • Squarepoint first reported a position in STAAR Surgical in Q4 2017 and has held it in 21 quarters since.
  • Squarepoint's STAAR Surgical position peaked at $6.48M in Q1 2026.
  • 200 funds tracked by Wall St. Rank held STAAR Surgical as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.